Literature DB >> 30556195

The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy.

Mahbobeh Satari1, Esmat Aghadavod1, Naghmeh Mirhosseini2, Zatollah Asemi1.   

Abstract

Diabetic retinopathy (DR) is one of the major complications of diabetes mellitus that causes diabetic macular edema and visual loss. DR is categorized, based on the presence of vascular lesions and neovascularization, into non-proliferative and proliferative DR. Vascular changes in DR correlate with the cellular damage and pathological changes in the capillaries of blood-retinal barrier. Several cytokines have been involved in inducing neovascularization. These cytokines activate different signaling pathways which are mainly responsible for the complications of DR. Recently; microRNAs (miRNAs) have been introduced as the key factors in the regulation of the cytokine expression which plays a critical role in neovascularization of retinal cells. Some studies have demonstrated that changing levels of miRNAs have essential role in the pathophysiology of vascular changes in patients with DR. The aim of this study is to identify the effects of miRNAs in the pathogenesis of DR via activating neovascularization pathways.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  diabetic retinopathy (DR); microRNAs (miRNAs); neovascularization

Year:  2018        PMID: 30556195     DOI: 10.1002/jcb.28227

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Effect of Shuangdan Mingmu Capsule on Diabetic Retinopathy in Rats via Regulation of miRNAs.

Authors:  Xiang Li; Yijing Yang; Yan Song; Fujiao Nie; Chaojun Fu; Yuhui Qin
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-19       Impact factor: 3.249

2.  MicroRNA-34a (miR-34a) Mediates Retinal Endothelial Cell Premature Senescence through Mitochondrial Dysfunction and Loss of Antioxidant Activities.

Authors:  Menaka C Thounaojam; Ravirajsinh N Jadeja; Marie Warren; Folami L Powell; Raghavan Raju; Diana Gutsaeva; Sandeep Khurana; Pamela M Martin; Manuela Bartoli
Journal:  Antioxidants (Basel)       Date:  2019-08-22

3.  Effects of long non-coding RNA myocardial infarction-associated transcript on retinal neovascularization in a newborn mouse model of oxygen-induced retinopathy.

Authors:  Yu Di; Yue Wang; Xue Wang; Qing-Zhu Nie
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

4.  Long non-coding RNA MEG3 inhibits neovascularization in diabetic retinopathy by regulating microRNA miR-6720-5p and cytochrome B5 reductase 2.

Authors:  Jinpeng Chen; Lin Liao; Huiyong Xu; Zheng Zhang; Jian Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 6.832

5.  Altered Expressions of Transfer RNA-Derived Small RNAs and microRNAs in the Vitreous Humor of Proliferative Diabetic Retinopathy.

Authors:  Yan Yang; Wenyun Yue; Nan Wang; Zicong Wang; Bingyan Li; Jun Zeng; Shigeo Yoshida; Chun Ding; Yedi Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

Review 6.  Role of interferons in diabetic retinopathy.

Authors:  Bing-Yan Li; Wei Tan; Jing-Ling Zou; Yan He; Shigeo Yoshida; Bing Jiang; Ye-Di Zhou
Journal:  World J Diabetes       Date:  2021-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.